JP6486645B2 - Volatilizer - Google Patents

Description

  The present invention relates to a volatilizer that volatilizes a liquid medicine.

  Conventionally, a volatilizer that volatilizes a liquid medicine in a room or a toilet is known. As such a volatilizer, for example, in Patent Document 1, a liquid absorbent core for sucking up a liquid medicine is inserted into a container, and a flat volatilization body and a cylindrical cover covering the volatilization body are provided on the top. An aroma diffuser is disclosed. This cover is provided with a volatilization hole for taking in the air current and diffusing the fragrance to the outside.

JP 2001-261080 A

  However, in the conventional volatilizer in which the volatilization hole is provided in such a cover, the airflow flowing through the part other than the volatilization hole of the cover is reflected and cannot be taken into the inside. On the other hand, there is a limit to increasing the opening area of the volatilization hole. Therefore, there is a problem that the volatilization efficiency of the liquid drug cannot be increased.

  Furthermore, in recent years, volatilizers are also required to be used as props for directing rooms as one of the interiors. However, the conventional volatilizer with a volatilization hole in the cover has many design restrictions, and it has not been possible to fully meet this demand for aesthetic enhancement.

  This invention is made | formed in view of the above background, The objective is to provide the volatilizer which can improve visibility and aesthetics while improving volatilization efficiency.

In order to solve the above-described problem, according to a preferred aspect of the present invention, a liquid medicine can be accommodated inside, a container having an opening in the upper part, and the liquid medicine can be absorbed from above the opening. A volatilizing body arranged to protrude, and a cap arranged to cover the volatilizing body, the volatilizing body extending radially outwardly from the main body and radially outward from the main body. The cap has a top portion disposed above the volatile body, a bottom portion disposed so as to surround a radially outer side of the volatile body, and the top portion and the bottom portion. And a plurality of fins arranged in a radial pattern , wherein the number of fins of the cap and the number of fins of the volatilization body are different .

  According to the said structure, after the liquid chemical | medical agent in a container is absorbed by the volatilization body, it vaporizes and volatilizes around. Here, the cap arrange | positioned so that a volatilization body may be covered is provided with the several fin. Since the fin connects the top and bottom of the cap and is arranged radially in plan view, not only the airflow toward the opening between the fin and the fin but also the side wall of the fin (the main surface of the fin along the radial direction) The airflow flowing toward the constituent surface) is also guided to the opening. Thereby, compared with the conventional volatilizer which provided the volatilization hole in the cover, a substantial opening area increases and it becomes possible to take in and take out the air efficiently from the volatilization body. As a result, the volatilization efficiency is improved.

  In addition, since the cap is composed of a plurality of fins arranged radially in plan view, the cap has a depth, that is, a three-dimensional extent, as compared to a conventional volatilizer provided with a volatilization hole in the cover. Can do. In addition, the degree of design freedom by the shape and arrangement of individual fins is widened, and it can be distinguished from the conventional volatilizer in terms of aesthetics.

  In the present invention, “radial” indicates a state in which a certain point or portion is centered at a regular interval or a different interval in a straight line or a curved line (for example, a spiral shape or a wave shape) in all directions.

Moreover, according to the said structure, since the surface area of a volatilization body increases with the several fin of a volatilization body, the quantity of the liquid chemical | medical agent evaporated from a volatilization body can be increased. Moreover, the airflow which hits the side wall part of the fin of a volatilization body is reflected according to the angle of a fin . Therefore, more complicated air turbulence can be generated in the airflow taken in from the cap. Thereby, the evaporation amount of the liquid medicine can be further increased, and air can be prevented from staying in the space between the cap and the volatilizer.

In addition, this volatilizer has a more complicated three-dimensional structure because a plurality of fins of the volatilization body are further disposed behind the fins of the cap. In addition, the shape and arrangement of the individual fins of the volatilizer increases the degree of design freedom compared to conventional plate-shaped volatilizers.

Further, according to the above configuration, by the number of fins in the number of fins of the cap and volatilization body is different, so that the angle between the fins of the cap, and the angle between the fins of the volatilization body different. In addition to the visual effect, a more complicated air turbulence can be generated in the airflow taken into the cap.

Preferably, the radial side surface of each fin of the cap may have a shape that twists or undulates from the top to the bottom.

  According to the said structure, the more complicated disturbance of air can be produced in the airflow taken in the inside of a cap with the said fin of the twist or the wave shape.

  Preferably, the apparatus further includes a flange attached to a neck portion of the container and having an opening at a center thereof, and the flange is provided on a radially outer side of the opening and is capable of mounting the volatilizer. And a second placement portion that is provided on the outer side in the radial direction of the first placement portion and on which the cap can be placed.

  According to the said structure, it can assemble easily only by mounting a volatilization body and a cap in order on the flange with which the neck part was mounted | worn. Moreover, since the removal of a cap and a volatilization body should just be performed in a reverse procedure, replacement | exchange of the liquid chemical | medical agent of a container, a liquid absorption core, etc. can be performed easily. Moreover, a cap and a volatilization body can be freely rotated and positioned on a flange, respectively. Thereby, for example, when the volatilization body is provided with a convex part, the mutual angle between the fin of the cap and the convex part of the volatilization body can be easily adjusted.

  Preferably, a volatilization prevention cover that is disposed between the volatilization body and the cap and covers the volatilization body, and a flat part that is mounted on the radially inner side of the neck of the container and on which the volatilization body can be placed. An inner flange; and an outer flange having a mounting portion that is threadably fitted to a radially outer side of the neck portion of the container and that can be fitted with the cap, wherein the outer flange is a flat portion of the inner flange. There may be an edge portion extending upward toward the neck portion, and the volatilization prevention cover may be sandwiched between the edge portion and the flat portion.

  According to the above configuration, the volatilization prevention cover is disposed between the volatilization body and the cap, and is disposed so as to cover the volatilization body, so that the liquid chemical is discharged from the volatilization body when the volatilizer is shipped or not used. Volatilization can be prevented. This volatilization prevention cover is clamped between the edge part of an outer side flange, and the flat part of an inner side flange. Since the outer flange is screwed onto the neck portion of the container, the interval between the edge portion of the outer flange and the flat portion of the inner flange is widened by loosening the screw fit to the neck portion of the outer flange. Thereby, a volatilization prevention cover can be easily removed from a volatilizer.

  Preferably, a liquid absorption core that is disposed in the container and absorbs the liquid medicine may be further provided, and an upper end of the liquid absorption core may be in contact with a part of the volatilization body.

  According to the said structure, the liquid absorption core arrange | positioned in a container absorbs a liquid chemical | medical agent. The absorbed liquid medicine is impregnated in the volatilization body through the portion where the volatilization body contacts from the upper end of the liquid absorption core. Since the volatilizer and the liquid absorbent core are separate, for example, when the volatilizer and the liquid absorbent core are physically separated at the time of shipment or when not used, the liquid chemical is further impregnated into the volatilized body. Can be prevented.

  Preferably, a part of the volatilization body may be disposed in the container so as to directly contact the liquid medicine.

  According to the said structure, a volatilization body sucks a liquid chemical | medical agent directly from the inside of a container, and volatilizes it. In this case, since the liquid absorption core as described above is not required, the number of parts can be reduced and the assembly is facilitated.

  ADVANTAGE OF THE INVENTION According to this invention, the volatilizer which can improve volatilization efficiency and can improve visibility and aesthetics can be provided.

It is a perspective view of the volatilizer which concerns on the 1st Embodiment of this invention. It is a perspective view of the flange of the volatilizer. It is a figure which shows the volatilization body of the volatilizer, (A) is a top view (B) is a perspective view. It is a figure which shows the cap of the volatilizer, (A) is a top view (B) is a perspective view. It is principal part sectional drawing of the volatilizer which concerns on the 2nd Embodiment of this invention. It is a figure which shows the volatilization body of the volatilizer, (A) is a top view (B) is a perspective view. It is a perspective view of the volatilizer which concerns on the modification of this invention. It is a perspective view of the cap which concerns on the modification of this invention.

  Hereinafter, a volatilizer according to a preferred embodiment of the present invention will be described with reference to the accompanying drawings. In the following description, the direction where the bottom of the container exists is the lower side, and the direction where the neck of the container exists is the upper side. In addition, in order to facilitate understanding of the description, the same components are denoted by the same reference numerals as much as possible in each drawing, and redundant description is omitted.

<First Embodiment>
As shown in FIG. 1, the volatilizer 1 according to the first embodiment of the present invention includes a container 2, a liquid absorbent core 3, a flange 4, a volatilizer 5, and a cap 6.

  In the container 2, a neck part 20, a body part 22, and a bottom part 24 are integrally formed in order from the upper side, and constitute a bottomed bottle-like bottle wall for storing a liquid medicine therein. As a liquid chemical | medical agent of the container 2, there exists what mixed 1 type, or multiple types, such as an aromatic liquid, a deodorizing liquid, a deodorizing liquid, an insect repellent liquid, and a fungicidal liquid. The container 2 has a spindle shape in which the diameter of the body portion 22 is the largest and the diameter is reduced toward the neck portion 20 and the bottom portion 24. The trunk portion 22 has a trough portion 220 that is formed to bend in a wave shape obliquely in the vertical direction from the neck portion 20 toward the bottom portion 24, and a crest portion 222 that smoothly connects between the trough portions 220 and rises outward in the radial direction of the container. It consists of and. The container 2 is made of, for example, colorless and transparent (or colored and transparent) plastic (or glass) or the like, and at the first glance, it has an aesthetic appearance like a perfume bottle.

  As shown in FIG. 1, the neck 20 of the container 2 is provided with an opening (not shown) that opens upward, and an inner cap (not shown) is fitted into the opening. A rod-shaped liquid absorbent core 3 is inserted through the center of the inner cap, and the liquid absorbent core 3 is held by the inner cap. The liquid absorbent core 3 is formed of fibers such as pulp and synthetic resin having liquid absorbency, for example. The liquid absorption core 3 is disposed on, for example, the central axis of the container 2, the lower end thereof is in contact with the bottom 24 of the container 2, and the upper end thereof extends above the inner cap so that the volatilizing body 5 placed on the flange 4 is placed. Touch the bottom. The liquid absorption core 3 guides the absorbed liquid medicine from the bottom to the top of the container 2 to permeate the volatilization body 5.

  As shown in FIG. 1, the flange 4 is attached to the neck 20 of the container 2. As shown in FIG. 2, the flange 4 includes a mounting portion 40 that is screwed onto the outer peripheral edge of the neck portion 20, and a wide annular portion 42 that is connected to the top of the mounting portion 40. The liquid absorbing wick 3 is inserted through 44. The flange 4 is made of plastic, for example.

  In the annular portion 42, a first placement portion 420 and a second placement portion 422 are formed in order from the opening 44 of the flange toward the radially outer side. The first mounting portion 420 and the second mounting portion 422 are each formed of an annular flat surface having the same central axis as the central axis of the container 2, and function as mounting surfaces for the volatilization body 5 and the cap 6. To do. A side wall 424 is formed on the outer peripheral edge of the first mounting portion so as to protrude upward in the vertical direction from the outer peripheral edge, and the radial movement of the volatilizing body 5 is restricted. In addition, side walls 426 and 428 are formed on the inner peripheral edge and the outer peripheral edge of the second mounting portion 422 so as to protrude upward in the vertical direction from each, so that the radial movement of the cap 6 is restricted. Yes.

  With the above configuration, the volatilization body 5 and the cap 6 can be easily mounted and positioned by simply mounting the volatilizing body 5 and the cap 6 in order on the mounting surface of the flange 4. Since the removal of the volatilization body 5 and the cap 6 may be performed in the reverse procedure, the exchange of the liquid medicine and the liquid absorbent core 3 can be performed very easily.

  As shown in FIG. 1, the volatilization body 5 is placed on the first placement portion 420 of the flange 4. As shown in FIGS. 3A and 3B, the volatilizing body 5 includes a cylindrical main body 50 and a plurality of convex portions 52 extending radially from the center of the main body 50 in a plan view. Each of the main body 50 and the convex portion 52 has a flat upper surface and bottom surface, and can be placed on the first placement portion 420 in any direction in the vertical direction. The volatilizing body 5 is placed on the first mounting part 420, and the upper end of the liquid absorbent core 3 comes into contact with the center of the lower surface of the volatilizing body 5.

  Eight convex portions 52 are arranged 45 degrees apart from each other in the circumferential direction. Each convex part 52 connects between two side wall parts 520 (the upper surface and the lower surface are connected to form a surface extending in the radial direction) and the two side wall parts 520 with a smooth curved surface bulging radially outward. And an end portion 522. The volatilization body 5 absorbs liquid by extruding a fiber bundle that is a mixture of one or more of polyolefin resins such as polyethylene and polypropylene, polyester resins such as polyethylene terephthalate and polybutylene terephthalate, and pulp. It is molded into a porous material so as to have properties.

  The liquid medicine that has penetrated into the volatilization body 5 through the liquid absorbent core 3 is vaporized from the surface of the volatilization body 5 and volatilizes outside. Since the volatilization body 5 has the convex part 52, since the surface area is remarkably large compared with the conventional plate-shaped or cylindrical volatilization body, the quantity of the liquid chemical | medical agent evaporated from the volatilization body 5 can be increased. . From another viewpoint, the same volatilization amount as that of the conventional volatilization body can be obtained with a smaller volume. That is, the volatilization body 5 can be reduced in size.

  Moreover, each convex part 52 of the volatilization body 5 reflects the airflow taken in from the cap 6 by the side wall part 520. Thereby, compared with a plate-shaped volatilization body, for example, the turbulence of the complicated air current can be caused by the air taken in from the cap 6. Thereby, air can be guide | induced to more locations of the volatilization body 5, the evaporation amount of a liquid chemical | medical agent can be increased, and it can suppress that air retains between the cap 6 and the volatilization body 5. .

  As shown in FIG. 1, the cap 6 is placed on the flange 4 so as to cover the volatilization body 5. As shown in FIGS. 4A and 4B, the cap 6 includes a conical top portion 60, an annular bottom portion 62, and a plurality of fins that are radially connected to the top portion 60 and the bottom portion 62. 64. The cap 6 is made of a transparent plastic. The cap 6 is formed by, for example, injection molding. The top 60 is disposed on the main body 50 of the volatilization body 5 and the bottom 62 is disposed so as to surround the convex part 52 of the volatilization body 5 while being placed on the second placement part 422 of the flange 4. Thereby, the cap 6 has a function as a cover of the volatilization body 5. That is, the cap 6 prevents a person or an object from coming into direct contact with the volatilizing body 5 infiltrated with the liquid medicine, or prevents the volatilizing body 5 from being blown off by the wind and falling from the container.

  Twelve fins 64 of the cap 6 are arranged 30 degrees apart from each other in the circumferential direction. Between each fin 64, the opening 66 for taking in and taking in air is formed. Each fin 64 has two side wall portions 640 each formed of a flat surface having a substantially “shaped” shape (a shape that once narrows and then widens again from the top 60 toward the bottom 62). It is comprised from the edge part 642 which connects between the two side wall parts 640 with a flat surface. The width of the end portion 642 (distance between the two side wall portions 640) is preferably as thin as possible if the cap 6 is sufficient for maintaining rigidity as a cover. Thereby, the space between the fins 64 adjacent to each other, that is, the opening 66 can be increased.

  Due to the structure of the cap 6 described above, not only the air flow directly toward the opening 66 but also the air flow flowing toward the side wall portion 640 of the fin 64 can be guided to the opening 66. That is, the substantial opening area increases as compared with a conventional volatilizer in which a volatilization hole is provided in the cover. Therefore, efficient air intake into the volatilization body 5 becomes possible, and the liquid medicine evaporating from the volatilization body 5 can be taken out efficiently.

  As described above, twelve fins 64 that are separated from each other by 30 degrees in the circumferential direction are disposed on the cap 6, while the eight protrusions 52 that are separated from each other by 45 degrees in the circumferential direction are disposed on the volatilizing body 5. Is arranged. Since the number of fins or convex portions of the cap 6 and the volatilizer 5 is different, most of the air flowing through the cap 6 is reflected at least once by the side wall portion 640 of the fin 64 or the side wall portion 520 of the convex portion 52. Will be. Thereby, a complicated disturbance can be caused by the air flow taken into the cap 6, and the air can be led to more locations of the volatilization body 5. As a result, the evaporation amount of the liquid medicine can be increased, and the retention of air between the cap 6 and the volatilizer 5 can be suppressed.

  Moreover, since the volatilization body 5 and the cap 6 can be freely rotated and positioned on the flange 4, respectively, the relative angle of the fin 64 of the cap 6 and the convex part 52 of the volatilization body 5 is made into the volatilizer, for example. It can be adjusted according to the airflow situation of the place where 1 is placed.

  The upper portion of the volatilizer 1 has a visually three-dimensional structure because the cap 6 and the volatilizer 5 each have fins or protrusions. And since the taking-in and taking-out efficiency of the volatilization body 5 and the cap 6 are good, both are reduced in size. More specifically, in the present embodiment, the size of the volatilizing body 5 in the radial direction is slightly smaller than the opening diameter of the neck portion 20 constituting the narrowest portion of the container 2, and the diameter of the cap 6 is The size of the direction is slightly larger than the opening diameter of the neck portion 20 and smaller than the diameter of the trunk portion 22 of the container 2. That is, the size in the radial direction of the volatilizing body 5 and the cap 6 is approximately the same as the diameter of the neck 20 of the container 2, and this is a three-dimensional structure having a depth due to the convex portions of the volatilizing body 5 and the fins of the cap 6 Combined with, the upper part of the volatilizer 1 has an aesthetic like a cap of a perfume bottle. As described above, the container 2 has an aesthetics like a perfume bottle, so when combined, the luminaire 1 has an aesthetics like a perfume bottle and its cap, and the volatilizer 1 is distinct from a conventional volatilizer. Have sex.

  Since the number of fins of the cap 6 is larger than the number of protrusions of the volatilization body 5, the fins 64 of the cap 6 visually shield part of the protrusions 52 of the volatilization body 5. Since the cap 6 has less design restrictions due to the material and shape than the volatilizing body 5, the volatilizing body 5 can be hidden behind the more attractive cap 6, and the visual shielding effect The beauty of the entire volatilizer 1 can be further improved.

<Second Embodiment>
Next, the volatilizer 10 which concerns on the 2nd Embodiment of this invention is demonstrated using FIG.5 and FIG.6. Here, the description will focus on the differences from the first embodiment, and the same components will be denoted by the same reference numerals and description thereof will be omitted.

  FIG. 5: is principal part sectional drawing which cut | disconnected the upper part of the volatilizer 10 which concerns on the 2nd Embodiment of this invention with the plane containing the central axis, The neck part 20, the liquid absorption core 3, and the volatilization body 5A of the container 2 The cap 6A, the inner flange 7, the outer flange 8, and the volatilization prevention cover 9 are shown.

  As shown in FIG. 6, the volatilizing body 5 </ b> A is provided with a through hole 54 for inserting the liquid absorbent core 3 through the central axis. In this embodiment, the liquid absorption core 3 is inserted to the lower half of the through hole 54 of the volatilizing body 5A, and the upper outer peripheral surface of the liquid absorption core 3 is in contact with the inner wall of the volatilization body 5A (see FIG. 5). Thereby, compared with 1st Embodiment (The upper surface of the liquid absorption core 3 contacts the bottom face of the volatilization body 5), the contact area of the liquid absorption core 3 and the volatilization body 5A becomes large, and a liquid chemical | medical agent is made efficient. It can be sucked up well in the volatilization body 5A.

  The volatilizing body 5 </ b> A is positioned and fixed by the liquid absorption core 3 and the inner flange 7. More specifically, the volatilizing body 5 </ b> A is erected along the central axis of the container 2 while the bottom end of the volatilizing body 5 </ b> A is placed on the flat portion 70 provided on the upper surface of the inner flange 7. It is positioned and fixed by the liquid absorption core 3.

  The inner flange 7 is provided with a fitting portion 72 on the outer periphery thereof. When the fitting portion 72 is fitted to the inner peripheral wall of the neck portion 20, the inner flange 7 is firmly fixed to the container 2 (in a state where rotation and removal are not easy). The inner flange 7 is connected to the inner side of the fitting portion 72 in the radial direction, a funnel-shaped funnel portion 74 whose diameter is reduced in the downward direction, and a lower portion of the funnel portion 74. And a tube 76 having a large diameter. The liquid absorption core 3 can be easily positioned and fixed in the container 2 by the wide diameter funnel portion 74 and the pipe 76 provided corresponding to the diameter of the liquid absorption core 3. In addition, the structure of the funnel 74 and the pipe 76 facilitates replenishment of the liquid medicine. An air hole 740 is provided in the funnel portion 74 so as to adjust a pressure change in the container 2 as the liquid medicine in the container 2 decreases.

  The cap 6 </ b> A has a mounting portion 60 </ b> A at its bottom, and the mounting portion 60 </ b> A is inserted into and engaged with the groove portion 80 of the outer flange 8, whereby the cap 6 </ b> A is mounted on the outer flange 8. The outer flange 8 has a threaded mounting portion 82 on its inner peripheral wall, and the outer flange 8 is screwed into the outer peripheral wall of the neck portion 20 that is also threaded, so that the outer flange 8 becomes the container 2. It is attached to. The outer flange 8 is further connected to the upper portion of the mounting portion 82 and further has an edge portion 84 extending radially inward.

  The volatilization prevention cover 9 is disposed between the volatilization body 5A and the cap 6A. The volatilization prevention cover has a cylindrical peripheral wall 90, an upper surface wall 92, and a lid portion 94 protruding radially outward from the lower end of the peripheral wall 90, and covers the entire outer peripheral surface except the bottom surface of the volatilization body 5A. Therefore, it can prevent that the air taken in through the cap 6A touches the volatilization body 5A. Thereby, it can prevent that a liquid chemical | medical agent volatilizes from the volatilization body 5A at the time of shipment of the volatilizer 10, a long-time non-use, etc.

  The lid portion 94 of the volatilization prevention cover 9 is sandwiched between the flat portion 70 of the inner flange 7 and the edge portion 84 of the outer flange 8, whereby the volatilization prevention cover 9 is fixed to the volatilizer 10. Of course, the volatilization prevention cover 9 needs to be removed when the volatilizer 10 is used. In this regard, in the structure of the present embodiment, it is easy to remove the volatilization prevention cover 9. That is, the outer flange 8 moves upward with respect to the container 2 by rotating the outer flange 8 and loosening the screw fitting of the mounting portion 82 to the neck 20 of the container 2. Then, since the space | interval of the flat part 70 of the inner side flange 7 and the edge part 84 of the outer side flange 8 spreads, suppression of the cover part 94 of the volatilization prevention cover 9 is cancelled | released. Thereby, the volatilization prevention cover 9 can be easily removed from the volatilizer 10.

<Modification>
Although the embodiments of the present invention have been described above, the present invention is not limited to these embodiments, and can be implemented in various modes without departing from the scope of the present invention.

  For example, although the structure which sucks up a liquid chemical | medical agent to a volatilization body through a liquid absorption core was shown above, as long as a liquid chemical | medical agent is absorbed by a volatilization body, it is not limited to this. For example, as shown in the volatilizer 100 in FIG. 7, a part of the volatilizer 5 </ b> B may be provided in the container and brought into direct contact with the liquid medicine. In this case, the volatilizer 5B also functions as a liquid absorption core, and can directly suck up and volatilize the liquid medicine. Since a liquid absorption core is not required, the number of parts can be reduced and assembly is facilitated. As shown in FIG. 7, in this modification, the volatile body 5 </ b> B extends to the bottom 24 of the container 2, and therefore the volatile body 5 </ b> B has an inner cap (not shown) fitted in the neck 22 of the container 2. ) And the bottom 24 of the container 2.

  Further, for example, the top and bottom of the cap, the shape of the fins, and the like can be appropriately changed as long as an opening to the volatilization body is ensured. For example, in the above embodiment, the top of the cap has a conical shape, but this may be an annular shape so that air is taken in from the top. For example, the shape, arrangement, and number of cap fins can be set as appropriate. For example, as shown in FIG. 8, seven fins 64B of the cap 6B may be provided at equal intervals, and the side wall portions 640B of the fins 64B may be configured by a twisted surface twisted in the axial direction. By configuring the fins in this manner, the airflow toward the inside of the cap 6B can be swung in the axial direction, and further disturbance can be caused in the captured airflow. In addition to the modified example, for example, the side walls of the fins may have a wave shape (curved surface having peaks and valleys) or a stepped shape including a plurality of steps.

  For example, the shape of the volatilization body can be changed as appropriate. For example, the shape of the side wall portion of the fin of the volatilizing body may be twisted or waved with respect to the axial direction, and the fin itself is provided on the volatilizing body as long as a surface area sufficient for evaporation of the liquid drug is ensured. For example, it may be cylindrical.

1, 10, 100 ... Volatilizer, 2 ... Container, 20 ... Neck, 22 ... Body, 220 ... Valley, 224 ... Mountain, 24 ... Bottom, 3 ... Liquid Absorbing Core, 4 ... Flange, 40 ... Mounting portion, 42 ... Ring portion, 420 ... First placement portion, 422 ... Second placement portion, 424, 426, 428 ... Side wall, 44 ... Opening, 5, 5A, 5B: Volatile body, 50: Main body, 52: Convex part, 520 Side wall part, 522 ... End part, 54 ... Through hole, 6 / 6A / 6B ... Cap, 60 / 60B …… Top, 60A …… Mounting, 62 / 62B …… Bottom, 64 / 64B …… Fin, 640 / 640B …… Sidewall, 642 / 642B …… End, 66 …… Open, 7 …… Inside Flange, 70 ... flat part, 72 ... fitting part, 74 ... funnel part, 76 ... pipe, 8 ... outer flange, 80 groove part, 82 ... mounting portion 84 ...... edge 9 ...... volatilization preventing cover, 90 ...... peripheral wall, 92 ...... top wall, 94 ...... lid

Claims (8)

A container capable of containing a liquid medicine inside and having an opening at the top;
A volatilizing body that absorbs the liquid medicine and is arranged to protrude from above the opening;
A cap arranged to cover the volatilization body,
The volatilization body has a main body and a plurality of fins extending radially outward from the main body in a radial direction,
The cap includes a top portion disposed above the volatilization body, a bottom portion disposed so as to surround a radially outer side of the volatilization body, and a plurality of caps radially disposed in a plan view connecting the top portion and the bottom portion. And fins ,
A volatilizer in which the number of fins of the cap is different from the number of fins of the volatilization body . The volatilizer according to claim 1, wherein the number of fins of the cap is larger than the number of fins of the volatilization body. Side wall portions of each fin of the cap has a twist Ru shape from the top toward the bottom, volatilization of claim 1 or 2. The volatilizer according to claim 1 or 2, wherein a side wall portion of each fin of the cap has a shape that undulates from the top portion toward the bottom portion. A flange attached to the neck of the container and having an opening in the center;
The flange is provided on the outer side in the radial direction of the opening and is provided on the outer side in the radial direction of the first mounting unit. The volatilizer as described in any one of Claims 1 thru | or 4 provided with the possible 2nd mounting part. A volatilization prevention cover that is disposed between the volatilization body and the cap and covers the volatilization body;
An inner flange having a flat portion that is mounted on the radially inner side of the neck of the container and on which the volatilization body can be placed;
An outer flange having a mounting portion that is screwed onto and mounted on the radially outer side of the neck of the container;
The outer flange has an edge extending toward the neck above the flat portion of the inner flange, and sandwiches the volatilization prevention cover between the edge and the flat portion. The volatilizer according to any one of claims 1 to 4.   The liquid absorption core which is arrange | positioned in the said container and absorbs the said liquid chemical | medical agent is further provided, The upper end of the said liquid absorption core is in contact with some volatilization bodies. The volatilizer according to one item.   The volatilizer according to any one of claims 1 to 4, wherein a part of the volatilizer is disposed in the container so as to directly contact the liquid medicine.

Images